The Bridging the Gap Plus (BG+) program aims to develop new approaches for treating spinal cord injury by integrating injury stabilization, regenerative therapy, and functional restoration. To achieve this combinatorial approach, BG+ teams will build two systems of implantable and adaptive devices. The first system will reduce injury effects during the early phases of spinal cord injury. This system will consist of active devices that conduct real-time biomarker monitoring and intervention to stabilize – and where possible, rebuild – the neural communications pathways at the site of injury. Biomarker monitoring will provide previously unavailable diagnostic information for automated or clinician-directed interventions. The second system will primarily address recovery of function in the final phase of spinal cord injury by deploying networks of stimulation and/or recording devices on the nervous system or relevant end organs to effectively “bridge the gap” of the spinal cord injury.
The BG+ program seeks to change the paradigm for spinal cord injury treatment. Successful BG+ devices will mitigate the early effects of injury, enhance clinical awareness and therapeutic options at the injury site, accelerate natural long-term recovery processes, and restore multiple nervous system functions.
You are now leaving the DARPA.mil website that is under the control and
management of DARPA. The appearance of hyperlinks does not constitute
endorsement by DARPA of non-U.S. Government sites or the information,
products, or services contained therein. Although DARPA may or may not
use these sites as additional distribution channels for Department of
Defense information, it does not exercise editorial control over all of
the information that you may find at these locations. Such links are
provided consistent with the stated purpose of this website.
After reading this message, click to continue